Clinical Trials Directory

Trials / Completed

CompletedNCT01566084

Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
University of Colorado, Boulder · Academic / Other
Sex
All
Age
50 Years – 79 Years
Healthy volunteers
Accepted

Summary

The investigators hypothesize that reducing salt in the diet will improve the function of blood vessels in middle aged and older adults with moderately elevated systolic blood pressure, by increasing the amount of BH4 and nitric oxide in your blood vessels and reducing the amount of oxidative stress.

Detailed description

The improvement in blood vessel function will be determined over a 10 week period. Subjects will be randomly assigned to either a 'low salt' condition (placebo pills + 1200 mg dietary sodium) or a 'normal salt' condition (2300 mg sodium chloride pills + 1200 mg dietary sodium) and monitored for 5 weeks. After the initial set of 5 weeks, the subjects are switched into the opposite condition, completing the cross-over study design. During weeks 1-4 and 6-9, subjects are monitored weekly with 24 hour urine collections and diet logs. The assessment of the primary outcome (blood vessel function) is completed during weeks 5 and 10. BH4 and ascorbic acid are also administered during weeks 5 and 10 to measure the effects of sodium intake on endogenous BH4 levels and vascular oxidative stress.

Conditions

Interventions

TypeNameDescription
DRUGSlow sodium tabletsThe normal salt condition is maintained with 2300 mg / day in the form of slowly released salt (NaCl) tablets.
OTHERplaceboPlacebo tablets are administered to maintain the low sodium condition.

Timeline

Start date
2009-02-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2012-03-29
Last updated
2016-01-07
Results posted
2014-06-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01566084. Inclusion in this directory is not an endorsement.